A Phase I Trial of Dose Escalated Irinotecan (CPT-11) With Paclitaxel in Patients With Metastatic or Recurrent Malignancies
Phase of Trial: Phase I
Latest Information Update: 05 Feb 2013
At a glance
- Drugs Irinotecan (Primary) ; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- 11 Sep 2005 New trial record.